Characteristics of Ph1+ ALL
| UPN . | WBC . | CD10 . | CD13 . | CD33 . | CD34 . | Ph+ (sp) . | Additional Abnormal Cytogenetics . | Courses to 1st CR . | CR 1 duration (mo) . | Extramed. Leukemia . |
|---|---|---|---|---|---|---|---|---|---|---|
| . | (×109/L) . | . | . | . | . | . | . | . | . | . |
| 5191 | 3 | + | − | − | − | + (NA) | −19, +22 | 1 | 9 | No |
| 7361 | 20 | + | − | − | − | + (p210) | No | 1 | 1 | CNS |
| 8124 | 4 | + | − | + | + | + (p210) | No | 2 | 3 | No |
| 9115 | 18 | + | − | − | − | + (NA) | −2, −13, −16 | 2 | 4 | No |
| 9222 | 38 | + | − | − | + | + (p190, p210) | No | 1 | 4 | No |
| 8278 | NA | + | − | − | − | + (NA) | No | 1 | 8 | No |
| 9861 | 16 | − | − | − | + | + (NA) | NA | 1 | 6 | No |
| 9833 | 30 | + | − | − | + | + (p190) | 9 p− | 1 | 4 | No |
| 7958 | 333 | + | − | − | − | + (p210) | No | 1 | 3 | CNS |
| 9635 | 10 | + | − | − | − | + (p210) | No | 1 | 10 | No |
| 4637 | 335 | + | − | − | − | + (NA) | −7, 9q− | 4 | 31 | No |
| 8765 | 85 | + | − | − | − | + (p190) | +12 | 1 | 7 | CNS |
| 6642 | 171 | + | − | − | − | + (p190) | 11q−, 13q−, −17, −20 | 2 | 6 | CNS |
| 8650 | NA | + | − | − | − | + (NA) | t1; 19 | 1 | 13 | CNS |
| 6056 | 93 | + | − | − | − | + (p190, p210) | 20q− | 1 | 3 | CNS |
| 5942 | 35 | + | + | + | − | + (p190, p210) | No | 1 | 2 | No |
| 4838 | 48 | + | − | − | − | + (NA) | 9p− | 1 | 4 | No |
| 7841 | 288 | + | − | + | + | + (NA) | t1; 15 | NA | NA | No |
| UPN . | WBC . | CD10 . | CD13 . | CD33 . | CD34 . | Ph+ (sp) . | Additional Abnormal Cytogenetics . | Courses to 1st CR . | CR 1 duration (mo) . | Extramed. Leukemia . |
|---|---|---|---|---|---|---|---|---|---|---|
| . | (×109/L) . | . | . | . | . | . | . | . | . | . |
| 5191 | 3 | + | − | − | − | + (NA) | −19, +22 | 1 | 9 | No |
| 7361 | 20 | + | − | − | − | + (p210) | No | 1 | 1 | CNS |
| 8124 | 4 | + | − | + | + | + (p210) | No | 2 | 3 | No |
| 9115 | 18 | + | − | − | − | + (NA) | −2, −13, −16 | 2 | 4 | No |
| 9222 | 38 | + | − | − | + | + (p190, p210) | No | 1 | 4 | No |
| 8278 | NA | + | − | − | − | + (NA) | No | 1 | 8 | No |
| 9861 | 16 | − | − | − | + | + (NA) | NA | 1 | 6 | No |
| 9833 | 30 | + | − | − | + | + (p190) | 9 p− | 1 | 4 | No |
| 7958 | 333 | + | − | − | − | + (p210) | No | 1 | 3 | CNS |
| 9635 | 10 | + | − | − | − | + (p210) | No | 1 | 10 | No |
| 4637 | 335 | + | − | − | − | + (NA) | −7, 9q− | 4 | 31 | No |
| 8765 | 85 | + | − | − | − | + (p190) | +12 | 1 | 7 | CNS |
| 6642 | 171 | + | − | − | − | + (p190) | 11q−, 13q−, −17, −20 | 2 | 6 | CNS |
| 8650 | NA | + | − | − | − | + (NA) | t1; 19 | 1 | 13 | CNS |
| 6056 | 93 | + | − | − | − | + (p190, p210) | 20q− | 1 | 3 | CNS |
| 5942 | 35 | + | + | + | − | + (p190, p210) | No | 1 | 2 | No |
| 4838 | 48 | + | − | − | − | + (NA) | 9p− | 1 | 4 | No |
| 7841 | 288 | + | − | + | + | + (NA) | t1; 15 | NA | NA | No |
Abbreviations: Additional Abnormal Cytogenetics, cytogenetics abnormalities in addition to the Ph+ clone; CNS, central nervous system; CR, complete remission; Extramed. Leukemia, extramedullary leukemia (at anytime pre-BMT); NA, not available; Ph+, Philadelphia chromosome-positive; sp, BCR/abl species by PCR; WBC, white blood cell count.